Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A serous adenocarcinoma that arises from the ovary and is characterized by the presence of a papillary architectural pattern.
Biomarker and diagnostic research for ovarian serous surface papillary adenocarcinoma has been reported in the published literature.
2 clinical trials registered. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
105 publications have been identified in PubMed for ovarian serous surface papillary adenocarcinoma. Research spans Case Report / Case Series (42%), Basic Science / Preclinical (28%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 44 |
Data assembled from 3 of 12 sources · Last updated Sep 21, 2026, 12:35 AM UTC
42%
Laboratory research | 29 | 28% |
Testing and diagnosis research | 14 | 13% |
Disease patterns and progression | 6 | 6% |
Research summaries | 5 | 5% |
Clinical study results | 5 | 5% |
New treatment approaches | 2 | 2% |
Li CL (2026). [PMID: 41957787](https://pubmed.ncbi.nlm.nih.gov/41957787/). *J Ovarian Res*. [Review / Meta-Analysis]
Slomovitz BM (2026). [PMID: 41385758](https://pubmed.ncbi.nlm.nih.gov/41385758/). *Journal of clinical oncology : official journal of the American Society of Clinical Oncology*. [Basic Science / Preclinical]
Xu M (2026). [PMID: 41889420](https://pubmed.ncbi.nlm.nih.gov/41889420/). *Front Oncol*. [Case Report / Case Series]
Saida T (2026). [PMID: 41047355](https://pubmed.ncbi.nlm.nih.gov/41047355/). *Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine*. [Clinical Trial Publication]
Waller B (2026). [PMID: 41021592](https://pubmed.ncbi.nlm.nih.gov/41021592/). *International journal of surgical pathology*. [Case Report / Case Series]
Swan EK (2026). [PMID: 41546492](https://pubmed.ncbi.nlm.nih.gov/41546492/). *Veterinary pathology*. [Case Report / Case Series]
Ghose Biswas A (2026). [PMID: 41728606](https://pubmed.ncbi.nlm.nih.gov/41728606/). *Frontiers in medicine*. [Diagnostic / Biomarker]
Zanfagnin V (2026). [PMID: 41887253](https://pubmed.ncbi.nlm.nih.gov/41887253/). *Arch Pathol Lab Med*. [Case Report / Case Series]
Zhang J (2026). [PMID: 41921934](https://pubmed.ncbi.nlm.nih.gov/41921934/). *Clin Nucl Med*. [Case Report / Case Series]
Aryal SC (2026). [PMID: 40827079](https://pubmed.ncbi.nlm.nih.gov/40827079/). *International journal of surgical pathology*. [Basic Science / Preclinical]